Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Supplement Demographic Expansion Drives Emerging Category Growth

This article was originally published in The Tan Sheet

Executive Summary

Consumers’ reasons for using supplements and the delivery formats they prefer are growing. Emerging growth categories include natural supplements and those aimed at heart health, diabetes and muscle-retention.

You may also be interested in...



Frutaceuticals Shed Sugar To Shake Up Gummy Supplement Market

Frutraceuticals are made with a technology that quickly evaporates moisture from heat-sensitive fruits to maintain raw material integrity without sugar, says marketer Frutarom Industries, which targets consumers seeking alternatives to vitamins in pill- and capsule-form but without sugar associated with gummies.

Spiked “Supplements” For Diabetes, Pain On The Rise

FDA is seeing supplements spiked with Rx ingredients indicated for pain management and diabetes treatment, and needs industry help identifying violators, CFSAN head Michael Landa says.

Regulatory News In Brief

FDA warns homeopathic firm; FDA deems “no complaints” inadequate response; NAD questions urinary control claims; Refunds for Disney and Marvel vitamins; more regulatory news in brief.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS106031

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel